Franklin W - Search Results

1

HER-2/neu as a therapeutic target in non-small cell lung cancer, prostate cancer, and ovarian cancer.

Agus DB, Bunn PA Jr, Franklin W, Garcia M, Ozols RF. Agus DB, et al. Among authors: franklin w. Semin Oncol. 2000 Dec;27(6 Suppl 11):53-63; discussion 92-100. Semin Oncol. 2000. PMID: 11236029 Review.

2

Epidermal growth factor receptor expression, signal pathway, and inhibitors in non-small cell lung cancer.

Bunn PA Jr, Franklin W. Bunn PA Jr, et al. Among authors: franklin w. Semin Oncol. 2002 Oct;29(5 Suppl 14):38-44. doi: 10.1053/sonc.2002.35646. Semin Oncol. 2002. PMID: 12422312 Review.

3

HER2/neu expression in malignant lung tumors.

Hirsch FR, Franklin WA, Veve R, Varella-Garcia M, Bunn PA Jr. Hirsch FR, et al. Semin Oncol. 2002 Feb;29(1 Suppl 4):51-8. doi: 10.1053/sonc.2002.31523. Semin Oncol. 2002. PMID: 11894014

4

Expression of target molecules in lung cancer: challenge for a new treatment paradigm.

Hirsch FR, Franklin WA, Bunn PA Jr. Hirsch FR, et al. Semin Oncol. 2002 Jun;29(3 Suppl 9):2-8. doi: 10.1053/sonc.2002.34265. Semin Oncol. 2002. PMID: 12094332 Review.

5

Epidermal growth factor receptor family in lung cancer and premalignancy.

Franklin WA, Veve R, Hirsch FR, Helfrich BA, Bunn PA Jr. Franklin WA, et al. Semin Oncol. 2002 Feb;29(1 Suppl 4):3-14. doi: 10.1053/sonc.2002.31520. Semin Oncol. 2002. PMID: 11894009 Review.

6

What is the role of HER-2/neu and trastuzumab (Herceptin) in lung cancer?

Hirsch FR, Franklin WA, Bunn PA. Hirsch FR, et al. Lung Cancer. 2002 Jun;36(3):263-4. doi: 10.1016/s0169-5002(02)00011-9. Lung Cancer. 2002. PMID: 12009235 No abstract available.

7

Preclinical studies of gemcitabine and trastuzumab in breast and lung cancer cell lines.

Hirsch FR, Helfrich B, Franklin WA, Varella-Garcia M, Chan DC, Bunn PA Jr. Hirsch FR, et al. Clin Breast Cancer. 2002 May;3 Suppl 1:12-6. doi: 10.3816/cbc.2002.s.003. Clin Breast Cancer. 2002. PMID: 12057039 Review.

8

EGFR and HER2 genomic gain in recurrent non-small cell lung cancer after surgery: impact on outcome to treatment with gefitinib and association with EGFR and KRAS mutations in a Japanese cohort.

Varella-Garcia M, Mitsudomi T, Yatabe Y, Kosaka T, Nakajima E, Xavier AC, Skokan M, Zeng C, Franklin WA, Bunn PA Jr, Hirsch FR. Varella-Garcia M, et al. J Thorac Oncol. 2009 Mar;4(3):318-25. doi: 10.1097/JTO.0b013e31819667a3. J Thorac Oncol. 2009. PMID: 19247083 Free PMC article.

9

Expression of Her-2/neu in human lung cancer cell lines by immunohistochemistry and fluorescence in situ hybridization and its relationship to in vitro cytotoxicity by trastuzumab and chemotherapeutic agents.

Bunn PA Jr, Helfrich B, Soriano AF, Franklin WA, Varella-Garcia M, Hirsch FR, Baron A, Zeng C, Chan DC. Bunn PA Jr, et al. Among authors: franklin wa. Clin Cancer Res. 2001 Oct;7(10):3239-50. Clin Cancer Res. 2001. PMID: 11595720

10

Evaluation of HER-2/neu gene amplification and protein expression in non-small cell lung carcinomas.

Hirsch FR, Varella-Garcia M, Franklin WA, Veve R, Chen L, Helfrich B, Zeng C, Baron A, Bunn PA Jr. Hirsch FR, et al. Among authors: franklin wa. Br J Cancer. 2002 May 6;86(9):1449-56. doi: 10.1038/sj.bjc.6600286. Br J Cancer. 2002. PMID: 11986780 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

571 results

Search Page

Filters